Tag Archive for: Biotech

Sometimes drugs need a bigger push to be more effective and reach their final destination:Expansion

The drug booster to the brain

Sometimes drugs need a bigger push to be more effective and reach their final destination: the brain.…
talento científicotalento cientifico

Founding a company in times of pandemic

Our CEO, Meritxell Teixidó was invited to the “Talento Científico” podcast to talk about the Gate2Brain…
Grit International Female Accelerator!Grit International Female Accelerator

G2B joined the Grit International Female Accelerator

Gate2Brain has been selected to be part of the 2022 cohort of the Grit International Female Accelerator. This…
Biotech New Frontiers Award 2022Gate2Brain

G2B awarded with Biotech New Frontiers 2022

Gate2Brain award with Biotech New Frontiers 2022 Gate2Brain attended the 5th Congress of Medical Biotechnology…
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJD

Nadia Calviño, First Vice President of the Government visits Gate2Brain

Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs, and Maria Eugènia…
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2Brain

Gate2Brain second anniversary

It’s Gate2Brain second anniversary!! The creativity, work and dedication of Gate2Brain's team can…
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient care

Gate2Brain at MIT Pitch Day at University of Cambridge

Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day at the University…
medicines beyond barriersG2B

Medicines beyond barriers

At Gate2Brain, we have found the key to unlocking the gate to the brain . We have developed a unique…
EITHealth Catapult 2022eithealth

Gate2Brain semifinalist of EITHealth’s Catapult 2022

We’re proud to share that Gate2Brain is semifinalist of EITHealth's Catapult 2022. Thanks to…
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.

Gate2Brain will be attending The Investment Readiness Series

On the 4th of July, Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series,…

Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

Meritxell Teixidó: “Una gran quantitat de fàrmacs no arriben al cervell, i la tecnologia de Gate2Brain…

‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer

Estas proteínas 'tractor' remolcan los fármacos hasta el cerebro como terapia contra un cáncer infantil…
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere

Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation

Next Wednesday, February 16, Gate2Brain will be in Transfiere, European Forum for Science, Technology…

G2B receives funding to accelerate its transfer to the market and society

Gate2Brain, a spin-off of Sant Joan de Déu (SJD), Institute for Research in Biomedicine (IRB) Barcelona…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social